Accueil>>Signaling Pathways>> Others>>BRD 7552

BRD 7552

Catalog No.GC10233

BRD 7552, un puissant inducteur du facteur de transcription PDX1, régule à la hausse l'expression de PDX1 dans les îlots humains primaires et les cellules canalaires, et induit des changements épigénétiques dans le promoteur PDX1 compatibles avec l'activation transcriptionnelle.

Products are for research use only. Not for human use. We do not sell to patients.

BRD 7552 Chemical Structure

Cas No.: 1137359-47-7

Taille Prix Stock Qté
10mg
87,00 $US
En stock
50mg
355,00 $US
En stock

Tel:(909) 407-4943 Email: sales@glpbio.com

Avis des clients

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

BRD7552 is an inducer of pancreatic and duodenal homeobox 1 (PDX1) [1][2].

PDX1 is a member of the homeodomain-containing transcription factor family. It is a key transcription factor important for both mature β cell function and pancreas development [1]. PDX1 is a master regulatory transcription factor and required for β-cell transdifferentiation [2].

In human cells, BRD7552 upregulated the expression of PDX1 via epigenetically altering PDX1 promoter area [3]. BRD7552 was discovered as a PDX1 inducer in a cell-based phenotypic screening assay. It was used to induce the expression of PDX1. In PANC-1 cells, BRD7552 up-regulated mRNA and protein levels of PDX1. BRD7552 changed epigenetic markers within the PDX1 promoter region that was consistent with transcriptional activation. In cell culture, BRD7552 partially complemented PDX1, enhancing insulin expression induced by the introduction of three genes in PANC-1 cells [2]. In PANC-1 cells, nine-day treatment with BRD7552 dose-dependently increased insulin mRNA expression. In primary human islet cells, three of five donor samples treated with BRD7552 showed significantly dose-dependent induction of PDX1 after 3 or 5 days and of insulin after a 5-day treatment [1]. BRD7552 was capable of inducing the expression of PDX1 in the human PANC-1 ductal cell line [4].

No in vivo application data of this product had been found.

References:
[1].  Yuan Y, Hartland K, Boskovic Z, et al. A small-molecule inducer of PDX1 expression identified by high-throughput screening[J]. Chemistry & biology, 2013, 20(12): 1513-1522.
[2].  Yuan Y. Small-Molecule Modulators of Pancreatic Ductal Cells: Histone Methyltransferases and β-Cell Transdifferentiation [D]. 2013.
[3].  Zhao Y. Developing Therapies with Functional Beta Cells to Treat Diabetes[J]. International Journal of Translational Science, 2015, 1: 41-66.
[4].  Fodor A, Cozma A, Karnieli E. Personalized epigenetic management of diabetes[J]. Personalized Medicine, 2015, 12(5): 497-514.

Avis

Review for BRD 7552

Average Rating: 5 ★★★★★ (Based on Reviews and 21 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for BRD 7552

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.